Canada is funding testing in Uganda of a popular off-patent antidepressant drug to fight a fungal brain disease that claims more than half a million lives in sub-Saharan Africa every year.
Sertraline, better known as Zoloft or Lustral, was first introduced by pharmaceutical giant Pfizer in 1991. It has since become the second-most prescribed antidepressant in the United States.
But recen
